The company added that it remained committed to protecting the interests of all stakeholders, including circulating credible and accurate information to the public
IT services firms are pushing managers to deploy AI tools in client work to boost productivity, improve efficiency and drive revenue growth amid a prolonged demand slowdown
Based on preliminary estimates with the government, the production value in FY26 is estimated to hit ₹227,000 cr, which is an increase of more than 24% over the previous financial year's ₹183,000 cr
NCLT approves Adani Enterprises' Rs 15,000 crore resolution plan for Jaiprakash Associates, dismissing Vedanta's objections and paving the way for takeover
New York-based Emergence will set up a Bengaluru AI lab focused on autonomous agents, aiming to expand frontier research, collaborate with IISc, and hire about 500 scientists
L Catterton's India consumer-focused fund has raised $200 million and aims for $400 million, with a $200 million greenshoe option to scale investments further
Novo Nordisk says competition in semaglutide will be driven by science and quality, not pricing, as multiple generic versions prepare to enter India after patent expiry
Audi India may revise its product strategy once clarity emerges on import duty cuts under the India-EU FTA, potentially expanding its model range across segments
India's transmission infrastructure may see Rs 1.65 lakh crore investments over three years, creating significant EPC opportunities across substations, railways and renewables
Ather Energy expands its service network to 500 centres across India, nearly doubling capacity to support growing EV adoption and strengthen after-sales service infrastructure
Lupin and Zydus Lifesciences enter a licensing pact to co-market semaglutide injection in India, aiming to improve access to therapies for diabetes and obesity
Renault India launches the all-new Duster with turbo petrol and hybrid options, advanced features, and introductory pricing, targeting strong demand in the competitive SUV segment
Semaglutide is a GLP-1 receptor agonist used to treat Type 2 Diabetes and, increasingly, for weight management by helping regulate blood sugar and appetite
KPIL has been awarded projects in the power transmission & distribution (T&D) sector in domestic and overseas markets, as well as in the buildings and factories (B&F) business in India